The guidelines aim to “provide greater clarity on how to scientifically validate the reprocessing instructions that are part of device labeling,” according to the FDA. The guidelines are targeted toward device manufacturers.
The FDA will host a public workshop to seek input from stakeholders, including healthcare providers, on June 8-9, 2011.
Read the FDA release on reusable medical devices.
Related Articles on Medical Devices and Supplies:
B Braun Receives Permanent Injunction in Patent Infringement Case
Expiring Patents May Produce Up to 90% Savings on Drugs
Integra Signs 3 Year Contract With Novation for Surgical Headlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
